(Q24243038)

1

0 references

Terry Seaton

2

0 references

George Bergus

3

0 references

Jim Jacobson

4

0 references

Cecilia Martínez-Monzón

Cochrane Database of Systematic Reviews

5

0 references

publication date

17 October 2007

0 references

published in

0 references

cites work

Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Fluconazole for the treatment of tinea capitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Ecology, epidemiology and diagnosis of tinea capitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Tinea capitis caused by Microsporum canis treated with terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Oral griseofulvin remains the treatment of choice for tinea capitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Pharmacologic basis for the treatment of tinea capitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Efficacy and tolerability of 8 weeks' treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Tinea capitis: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

The optimal therapy for tinea capitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Diagnosis and management of scalp ringworm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Tinea capitis: an overview with emphasis on management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Pediatric tinea capitis: recognition and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

Treating tinea capitis: should ketoconazole replace griseofulvin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

7 January 2021

Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

7 January 2021

A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

7 January 2021

Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

7 January 2021

Guidelines for the management of tinea capitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

7 January 2021

Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

7 January 2021

Double blind study of ketoconazole and griseofulvin in dermatophytoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

7 January 2021

Comparison of ketoconazole and griseofulvin for treatment of tinea capitis in childhood: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

7 January 2021

A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

7 January 2021

Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD004685.PUB2

1 reference

7 January 2021